Bang Oh Young, Liebeskind David S, Buck Brian H, Yoon Sa Rah, Alger Jeffry R, Ovbiagele Bruce, Saver Jeffrey L
Department of Neurology, University of California, Los Angeles, CA, USA.
J Neuroimaging. 2009 Oct;19(4):317-22. doi: 10.1111/j.1552-6569.2008.00303.x. Epub 2008 Oct 21.
Reperfusion of penumbral tissue is a promising strategy for treatment of acute cerebral ischemia more than 3 hours from symptom onset. However, there has been only sparse direct evidence that reperfusion after 3 hours prevents infarct growth.
We analyzed clinical and serial magnetic resonance imaging (MRI) data on patients who received endovascular recanalization therapy 3-12 hours after last known well time. Multimodal MRIs were acquired pretreatment, early (1-20 hours), and late (2-7 days) after treatment. Degree of recanalization was assessed on end of procedure catheter angiogram, degree of reperfusion on early posttreatment perfusion MRI, and infarct growth by analysis of diffusion lesion volumes on pretreatment and late MRIs.
Twenty-seven (12 men, 15 women) underwent endovascular recanalization procedures at 6.0 +/- 2.1 hours (range, 3.0-11.5 hours) after last known well time. Immediate posttreatment perfusion lesion (Tmax > or =4 seconds) volume correlated strongly with infarct growth (r= .951, P < .001), exceeding the correlations of vessel recanalization score (r=-.198, P= .446) and pretreatment diffusion-perfusion mismatch volume (r= .518, P= .033). Without reperfusion, enlargement of DWI lesion volume was observed in all patients, and extent of enlargement depended on volume of immediate posttreatment perfusion defects.
Our data indicate that posttreatment reperfusion is the major determinant of threatened tissue outcome, and suggest reperfusion even after 3 hours of symptom onset can alter tissue fate over a wide range of mismatch volumes.
对症状出现超过3小时的急性脑缺血患者,半暗带组织再灌注是一种很有前景的治疗策略。然而,仅有稀少的直接证据表明3小时后再灌注可防止梗死灶扩大。
我们分析了在最后一次已知健康时间3至12小时接受血管内再通治疗患者的临床和系列磁共振成像(MRI)数据。在治疗前、早期(1至20小时)和晚期(2至7天)获取多模态MRI。在手术结束时通过导管血管造影评估再通程度,在治疗后早期灌注MRI上评估再灌注程度,并通过分析治疗前和晚期MRI上的扩散病变体积评估梗死灶扩大情况。
27例患者(12例男性,15例女性)在最后一次已知健康时间后6.0±2.1小时(范围3.0至11.5小时)接受了血管内再通手术。治疗后即刻灌注病变(Tmax≥4秒)体积与梗死灶扩大密切相关(r = 0.951,P < 0.001),超过血管再通评分(r = -0.198,P = 0.446)和治疗前扩散 - 灌注不匹配体积(r = 0.518,P = 0.033)的相关性。若无再灌注,所有患者均观察到弥散加权成像(DWI)病变体积增大,且增大程度取决于治疗后即刻灌注缺损的体积。
我们的数据表明,治疗后再灌注是受威胁组织转归的主要决定因素,并提示即使在症状出现3小时后再灌注也可在广泛的不匹配体积范围内改变组织命运。